Back to Search
Start Over
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
- Source :
-
Blood cancer journal [Blood Cancer J] 2021 Nov 13; Vol. 11 (11), pp. 180. Date of Electronic Publication: 2021 Nov 13. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 11
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Publication Type :
- Editorial & Opinion
- Accession number :
- 34775463
- Full Text :
- https://doi.org/10.1038/s41408-021-00551-y